RISE Integrated Mental Health in York, Maine, offers ketamine therapy for trauma and depression, attracting patients ...

Bay Psychiatric Associates is excited to announce a successful Open House event at its newly expanded San Mateo location, ...

When Matt Thierfelder began his career as a Vancouver firefighter in 1994, the weight of unspoken rules hung over him: Don’t show weakness and don’t be vulnerable.

Research on synthetic psychedelics progresses, and there's hope to prove psilocybin safe and effective in intractable ...

There is one form of ketamine called Spravato that was approved ‒ I think it was in 2019 ‒ and it’s a nasal spray. And that was the first time the FDA had approved a form of ketamine for ...

This article was published by IBN, a multifaceted communications organization engaged in connecting public companies to the ...

The FDA has approved Janssen’s antidepressant nasal spray Spravato, making it the first new type of depression treatment to hit the market in 30 years – although its use will be restricted to ...

Spravato is the first ketamine-based medicine approved to treat depression, and also the first of a new class of glutamate NMDA receptor-targeting drugs that have ended a decades-long drought at ...

Atai Life Sciences is making incremental progress towards opening door for a first psychedelic treatment for depression. Read ...

The acquisition of Cohen and Associates, a respected interventional psychiatry practice, by NRx subsidiary HOPE Therapeutics, is expected ...

Stella Mental Health Boston specializes in Spravato (esketamine) nasal spray, transcranial magnetic stimulation (TMS), ketamine infusion therapy, stellate ganglion blocks (SGB) and medication ...